Stock Price Quote

PRIVI SPECIALITY CHEMICALS LTD.

NSE : PRIVISCLBSE : 530117ISIN CODE : INE959A01019Industry : ChemicalsHouse : Fairfax India
BSE3672.20-13.9 (-0.38 %)
PREV CLOSE ( ) 3686.10
OPEN PRICE ( ) 3660.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2064
TODAY'S LOW / HIGH ( )3651.50 3701.50
52 WK LOW / HIGH ( )2175 3770
NSE3675.60-0.9 (-0.02 %)
PREV CLOSE( ) 3676.50
OPEN PRICE ( ) 3667.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 3675.60 (157)
VOLUME 28124
TODAY'S LOW / HIGH( ) 3644.20 3707.90
52 WK LOW / HIGH ( )2173.2 3760
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 25-05 1985
Management Info
Mahesh P Babani - Chairman Mahesh P Babani - Managing Director
Registered Office

Address Privi House, A-71, T T C,Thane- Belapur Road,Kopar Khairne Railway Station,
Navi Mumbai,
Maharashtra-400710

Phone 022-68713200 / 33043500 / 33043600 / 27783040 / 27783041 / 27783045

Email enquiry@privi.co.in

Website www.privi.com

Registrars Details
MUFG Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE

NEWS

02Jan Privi Speciality Chemicals informs abo
Privi Speciality Chemicals has informed that it enclosed disclosure unde..
01Jan Privi Speciality Chemicals informs abo
Privi Speciality Chemicals has informed about disclosure under Regulatio..
24Dec Privi Speciality Chemicals informs abo
Privi Speciality Chemicals has informed that as per Company’s Code of Co..
20Dec Privi Speciality Chemicals informs abo
In compliance with Regulation 30 of SEBI (Listing Obligations and Disclo..
07Jul Privi Speciality Chemicals informs ab
Further to its letter dated July 05,2025, and in terms of Regulation 47..

Financials

in Millions
QTR Mar 26 ANNUAL 26
Net Profit1027.183574.41
Gross Profit 1378.47 4789.86
Operating Profit 1853.186760.33
Net Sales 6603.4724555.35

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Solar Industries Ind (BSE)
peergroup  19029.75 (3.08%)
M.Cap ( in Cr)172200.31
Tatva Chintan Pharma (BSE)
peergroup  1714.10 (20.00%)
M.Cap ( in Cr)4009.63
Navin Fluorine Intl. (BSE)
peergroup  7856.10 (3.73%)
M.Cap ( in Cr)40301.81
Elantas Beck India (BSE)
peergroup  9455.00 (1.96%)
M.Cap ( in Cr)7495.62
Gujarat Fluorochem. (BSE)
peergroup  4313.90 (3.89%)
M.Cap ( in Cr)47388.19

Shareholding Pattern

MUTUAL FUNDS/UTI 8.55%
PROMOTERS 60.6%
NON-INSTITUTION 27.38%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Privi Speciality Chemicals Ltd.

Privi Speciality Chemicals Ltd. was incorporated in the year 1985. Its today's share price is 3672.2. Its current market capitalisation stands at Rs 14344.61 Cr. In the latest quarter, company has reported Gross Sales of Rs. 24555.35 Cr and Total Income of Rs.24724.19 Cr. The company's management includes Priyamvada Bhumkar, Hemang Manhar Gandhi, Naresh Madhu Tejwani, Anurag Surana, Bhaktavatsala Rao Doppalapudi, Mahesh P Babani, Mahesh P Babani, Ashwini Saumil Shah.

It is listed on the BSE with a BSE Code of 530117 , NSE with an NSE Symbol of PRIVISCL and ISIN of INE959A01019. It's Registered office is at Privi House, A-71, T T C,Thane- Belapur Road,Kopar Khairne Railway StationNavi Mumbai-400710, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co LLP, Jhaveri Shah & Co, Price Waterhouse & Co, Price Waterhouse & Co Chartered Accountants LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.